Protocol No.: NRG-BR009

Title
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score </= 25 (OFSET)
Principal Investigator
Kurian, Sobha
Phase
III
Age Group
Adult
Applicable Disease Site
Breast Cancer
Participating Institutions
Mary Babb Randolph Cancer Center
United Hospital Center
Contacts
Emily Hawkins, BSN
Research Nurse
Phone: +1 304-293-7375
Maher Kali, MD
Clinical Research Specialist
Phone: +1 304-243-7045
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000

View on ClinicalTrials.gov